78P Dynamic immune modulation by dendritic cell vaccination and IFN-α in advanced melanoma: Final insights from the ABSIDE phase II trial

Advanced melanoma remains a clinical challenge despite therapeutic progress. The ABSIDE trial investigated an autologous dendritic cell vaccine (DCvax) alone or in combination with radiotherapy (RT) and/or short-course IFN-α to evaluate safety, clinical activity, and immune modulation.

Authors

Institutions

Publication Details

Journal
Immuno-Oncology Technology
Published
2025-12-01
DOI
https://doi.org/10.1016/j.iotech.2025.101163
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

78P Dynamic immune modulation by dendritic cell vaccination and IFN-α in advanced melanoma: Final insights from the ABSIDE phase II trial

J. Bulgarelli
Immuno-Oncology Technology
Immunotherapy and Immune Responses
article

78P Dynamic immune modulation by dendritic cell vaccination and IFN-α in advanced melanoma: Final insights from the ABSIDE phase II trial

J. Bulgarelli
article en

Abstract

Advanced melanoma remains a clinical challenge despite therapeutic progress. The ABSIDE trial investigated an autologous dendritic cell vaccine (DCvax) alone or in combination with radiotherapy (RT) and/or short-course IFN-α to evaluate safety, clinical activity, and immune modulation.

Immuno-Oncology TechnologyVol. 28
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
Good health and well-being
Openalex Percentile: Top 36%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

78P Dynamic immune modulation by dendritic cell vaccination and IFN-α in advanced melanoma: Final insights from the ABSIDE phase II trial — J. Bulgarelli · Immuno-Oncology Technology (2025) | TGRS Research Map | TGRS